Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F91YD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,467 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injector sets. The contract, which was competitively awarded without a set-aside designation, is effective through February 12, 2026, and utilizes firm fixed-price pricing. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. SKYRIZI is a biologic immunosuppressant medication used to treat moderate-to-severe plaque psoriasis and other inflammatory conditions, representing one of numerous pharmaceutical products the company supplies to the federal government's medical supply chain.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, a $999.9 billion vehicle valued through December 2031 that enables comprehensive pharmaceutical and medical supply support for military healthcare programs globally. Cencora's DLA IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, positioning AmerisourceBergen as a critical vendor for Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent award of competitively bid delivery orders demonstrates its established capability to meet federal pharmaceutical procurement requirements at scale.
Quick answers
Who was awarded contract SPE2DR26F91YD?
SPE2DR26F91YD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F91YD worth?
The government has obligated $12,467 on SPE2DR26F91YD.
Is contract SPE2DR26F91YD an order under another contract?
Yes. SPE2DR26F91YD is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F91YD competed?
The extent of competition for SPE2DR26F91YD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award